Related Experiment Video
Updated: Jan 8, 2026

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
Published on: March 21, 2021
The association between composite dietary antioxidant index and sarcopenic obesity
Xi Luo1, Weiwei Jin2
1Department of Clinical Nutrition, Tongde Hospital of Zhejiang Province, Hangzhou, China. luoxi0571@sina.com.
Background And Objective:
The composite dietary antioxidant index (CDAI) is a tool to assess an individual's comprehensive dietary antioxidant intake profiles. This study aimed to explore the association between energy-adjusted composite dietary antioxidant index (E-CDAI) and sarcopenic obesity (SO).
Methods:
Participants from the NHANES cohort (n = 4388) and the Tongde Hospital of Zhejiang Province cohort (n = 276) were enrolled in the present study. Logistic regression analyses were applied to explore the association between E-CDAI (both continuous and quintiles) and SO. Moreover, the mediating effect of inflammatory/nutritional indicators were evaluated to investigate the association between E-CDAI and SO.
Results:
In the NHANES cohort, logistic regression demonstrated a significant inverse correlation between E-CDAI and SO (adjust odd ratio (OR)continuous =0.89, 95% CI = 0.81, 0.98, P = 0.041; adjust ORQ5vsQ1 =0.44, 95% CI = 0.29, 1.18, Ptrend =0.050) In the Chinese population cohort, an inverse correlation also existed between E-CDAI and SO (adjust ORcontinuous =0.72, 95% CI = 0.60, 0.87, P < 0.001; adjust ORQ5vsQ1 =0.30, 95% CI = 0.13, 0.74, Ptrend <0.001). Applying data from the NHANES cohort, the mediation analysis indicated that neutrophil-percentage-to-albumin ratio mediated 12.812% and C-reactive protein mediated 6.485% of the associations between E-CDAI and SO.
Conclusion:
A decreased E-CDAI score is associated with the increased risk of SO in adults. The association appeared to be partially mediated through inflammatory/nutritional pathways, suggesting that the E-CDAI may serve as a valuable indicator for identification of individuals at risk for SO.
More Related Videos
Related Concept Videos
Coronary Artery Disease I: Introduction
Obesity
Self-Schemas
Atherosclerosis III: Management
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

